Halberd Corporation
HALB
Rank in Stocks
#33034
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Share Price
$0.0018
Last synced: 2026-11-09
Market Cap
$928.58K
Change (1 day)
5.88%
Change (1 year)
5.88%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Halberd Corporation (HALB)
Category
Healthcare
Operating Margin for Halberd Corporation (HALB)
Operating Margin as of November 2026 TTM: 0.00%
According to Halberd Corporation's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Halberd Corporation from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -7,512.51% | -54.22% |
| 2023 | -16,410.79% | -18.69% |
| 2022 | -20,182.43% | 23.55% |
| 2021 | -16,335.99% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | -157.38% | -446.27% |
| 2016 | 45.45% | -121.84% |
| 2015 | -208.08% | 7.90% |
| 2014 | -192.85% | 180.51% |
| 2013 | -68.75% | -243.35% |
| 2012 | 47.96% | 17.12% |
| 2011 | 40.95% | -105.95% |
| 2010 | -688.60% | -95.25% |
| 2009 | -14,504.11% | 2,597.64% |
| 2008 | -537.66% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Halberd Corporation's operating margin
What was Halberd Corporation's operating margin in 2025?
In 2025, Halberd Corporation's operating margin was 0.00%, compared with -7,512.51% in 2024.
How has Halberd Corporation's operating margin changed since 2020?
From 2020 to 2025, Halberd Corporation's operating margin was highest in 2025 (0.00%) and lowest in 2022 (-20,182.43%).
How does Halberd Corporation's operating margin compare with similar companies?
Halberd Corporation's operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.